U.S. Fertility Market: Fertility Crises Spurs Demand

The U.S. fertility market size is calculated at USD 5,750 million in 2024 and is predicted to reach around USD 9,190 million by 2034, expanding at a CAGR of 4.8% from 2025 to 2034.

U.S. Fertility Market Report Highlights

• By offering, the assisted reproductive technology segment maintained a leading position in the market in 2024.
• By offering, the fertility drugs segment is projected to expand rapidly in the market in the coming years.
• By end user, the fertility clinics segment held a dominant presence in the market in 2024.
• By end user, the hospitals segment is set to experience the fastest rate of market growth from 2025 to 2034.

The U.S. fertility market is seeing remarkable growth with the rising incidence of infertility, late pregnancy, and developments in assisted reproductive technology. Fertility treatments such as IVF, intrauterine insemination (IUI), and fertility preservation treatments are becoming increasingly accepted as increasing numbers of couples and individuals look to reproductive solutions. Technological advancements, expanding insurance coverage, and changing cultural trends toward delaying parenthood are all contributing factors to the market's growth. The market is expected to grow steadily in the upcoming years as research and innovation continue to increase success rates.

One of the key drivers of the US market for fertility is the rising incidence of infertility, which affects the lives of millions of American people. Changing lifestyles have led to an increase in stress, poor nutrition, obesity, smoking, and delayed childbearing, leading to diminishing fertility levels. The rising occurrence of reproductive conditions such as endometriosis and polycystic ovary syndrome (PCOS) is leading to a rise in infertility. As a result, there is an increasing need for hormonal therapies and IVF, among other fertility treatments. As infertility becomes a more prevalent problem, more people are choosing medical treatments, which is propelling market expansion.

Industry Valuation and Growth Rate Projection

The fertility treatments have changed as a result of the rapid advancement of assisted reproductive technology (ART). Developments like preimplantation genetic testing (PGT), embryo freezing, and sophisticated hormone therapies have enhanced IVF success rates. Furthermore, methods like artificial intelligence (AI)-based embryo selection and time-lapse imaging are improving treatment accuracy. These advancements are increasing the efficiency and accessibility of fertility treatments, driving U.S. fertility market growth.

Attitudes towards fertility treatments have changed radically, and there is greater acceptance of assisted reproductive practices, surrogacy, and associated services. More awareness campaigns, celebrity endorsements, and the popularity of benefits being offered to employees for family planning are making the use of reproductive technology the new normal. Convenient payment plans and insurance coverage for fertility treatment are also making the services accessible, and more individuals are seeking treatment.

Despite some advancements in treatment for fertility, the high costs incurred during treatment continue to be an issue. Egg freezing, surrogacy, and IVF are expensive treatments, and it often takes individuals several attempts at it before conception occurs. Inadequate insurance coverage for fertility treatment leaves most individuals without the means for treatment. Despite the existence of some companies with fertility benefits, cost remains an issue, keeping the market in check.

Artificial intelligence (AI) is transforming the U.S. fertility market by making reproductive therapy more effective and targeted. AI is greatly benefitting embryo selection technology, taking into account many variables that determine and optimize the highest chance of implantation, improving overall success rates. AI is also streamlining laboratory work, optimizing hormone therapy, and predicting how patients will respond, leading to more customized fertility treatment. With AI employed in assisted reproductive technology (ART) treatments, clinics are improving patient results while saving money and shortening treatment periods.

As falling birthrates continue to be a concern among certain sects of the population, companies are providing fertility benefits, including IVF, egg freezing, and surrogacy, covered along with other employee medical benefits. With more companies implementing fertility-friendly policies, the scope of treatments will increase, propelling market growth. With an increasing number of people delaying conception, the demand for egg and sperm freezing services is on the rise. Improved cryopreservation methods make fertility preservation easier and more efficient, attracting individuals interested in planning pregnancies in the future. Most individuals travel overseas for fertility treatment owing to lower costs and legal matters. The US is emerging as a medical tourism destination for fertility care, attracting foreign patients who desire quality reproductive care and presenting more U.S. fertility market opportunities.